Bitcoin (btc)$86,768.00↑ 7.30%
Ethereum (eth)$2,776.81↑ 5.82%
Tether (usdt)$0.9998↑ 0.01%
BNB (bnb)$805.93↑ 5.30%
XRP (xrp)$1.55↑ 10.33%
USDC (usdc)$0.99986↑ 0.01%
Solana (sol)$119.53↑ 8.84%
TRON (trx)$0.344271↑ 0.49%
Zcash (zec)$1,457.78↓ 1.81%
Figure Heloc (figr_heloc)$1.013↑ 0.00%
Hyperliquid (hype)$93.57↑ 0.96%
Dogecoin (doge)$0.099329↑ 14.46%
Monero (xmr)$596.91↑ 6.25%
WhiteBIT Coin (wbt)$87.29↑ 5.74%
Rain (rain)$0.013988↓ 0.67%
Bitcoin (btc)$86,768.00↑ 7.30%
Ethereum (eth)$2,776.81↑ 5.82%
Tether (usdt)$0.9998↑ 0.01%
BNB (bnb)$805.93↑ 5.30%
XRP (xrp)$1.55↑ 10.33%
USDC (usdc)$0.99986↑ 0.01%
Solana (sol)$119.53↑ 8.84%
TRON (trx)$0.344271↑ 0.49%
Zcash (zec)$1,457.78↓ 1.81%
Figure Heloc (figr_heloc)$1.013↑ 0.00%
Hyperliquid (hype)$93.57↑ 0.96%
Dogecoin (doge)$0.099329↑ 14.46%
Monero (xmr)$596.91↑ 6.25%
WhiteBIT Coin (wbt)$87.29↑ 5.74%
Rain (rain)$0.013988↓ 0.67%

Ten63 Therapeutics Announces Collaboration with Boehringer Ingelheim for Drug Discovery – Draper Decentralized – 5.31.24

Published May 31, 2024

Ten63 Therapeutics, a biotechnology company specializing in advanced AI and physics-based models to tackle undruggable diseases, has partnered with Boehringer Ingelheim for multi-target drug discovery. This collaboration aims to develop new therapeutic molecules for diseases that conventional methods have not been able to treat, addressing significant unmet patient needs.